SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-18-000003
Filing Date
2018-02-06
Accepted
2018-02-06 08:11:44
Documents
66
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311710-q.htm 10-Q 1244919
2 EXHIBIT 3..1 amendedandrestatedbylaws.htm EX-3..1 234060
3 EXHIBIT 10.1 aslanlicenseagreementredac.htm EX-10.1 302478
4 EXHIBIT 31.1 a123117ex311.htm EX-31.1 14803
5 EXHIBIT 31.2 a123117ex312.htm EX-31.2 14050
6 EXHIBIT 32.1 a123117ex321.htm EX-32.1 11771
  Complete submission text file 0001100412-18-000003.txt   7747254

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arry-20171231.xml EX-101.INS 1613195
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20171231.xsd EX-101.SCH 51600
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20171231_cal.xml EX-101.CAL 69049
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20171231_def.xml EX-101.DEF 337788
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20171231_lab.xml EX-101.LAB 712620
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20171231_pre.xml EX-101.PRE 455616
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 18576249
SIC: 2834 Pharmaceutical Preparations